Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-04 4:19 pm |
NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer |
268 | $18.92 | $5,071 | 166,243 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 4:19 pm |
NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology |
2,527 | $18.54 | $46,841 | 143,673 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 4:19 pm |
NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer |
2,053 | $18.54 | $38,055 | 204,005 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 4:16 pm |
NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer |
250 | $18.54 | $4,634 | 29,173 (Direct) |
View |
| 2025-02-28 Sale(A) |
2025-03-03 9:27 pm |
NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer |
4,637 | $18.75 | $86,949 | 166,511 (Direct) |
View |
| 2025-02-27 Sale(A) |
2025-03-03 9:26 pm |
NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer |
13,494 | $19.72 | $266,126 | 206,058 (Direct) |
View |
| 2025-02-27 Sale(A) |
2025-03-03 9:26 pm |
NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology |
15,036 | $19.7 | $296,257 | 146,200 (Direct) |
View |
| 2025-02-27 Sale(A) |
2025-03-03 9:26 pm |
NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer |
1,387 | $20.02 | $27,773 | 108,706 (Direct) |
View |
| 2025-02-27 Sale(A) |
2025-03-03 9:26 pm |
NovoCure Ltd | NVCR | Leupin Nicolas Chief Medical Officer |
991 | $20.02 | $19,844 | 50,133 (Direct) |
View |
| 2025-02-27 Sale(A) |
2025-03-03 9:26 pm |
NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer |
2,014 | $19.71 | $39,688 | 29,423 (Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:28 pm |
NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer |
4,637 | $18.75 | $86,949 | 166,511 (Direct) |
View |
| 2025-02-27 Sale |
2025-03-03 4:28 pm |
NovoCure Ltd | NVCR | Leupin Nicolas Chief Medical Officer |
991 | $20.02 | $19,844 | 50,133 (Direct) |
View |
| 2025-02-27 Sale |
2025-03-03 4:27 pm |
NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer |
1,387 | $20.02 | $27,773 | 108,706 (Direct) |
View |
| 2025-02-27 Sale |
2025-03-03 4:27 pm |
NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology |
15,036 | $19.7 | $296,257 | 146,200 (Direct) |
View |
| 2025-02-27 Sale |
2025-03-03 4:26 pm |
NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer |
13,494 | $19.72 | $266,126 | 206,058 (Direct) |
View |
| 2025-02-27 Sale |
2025-03-03 4:26 pm |
NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer |
2,014 | $19.71 | $39,688 | 29,423 (Direct) |
View |
| 2025-01-11 Sale |
2025-01-15 4:23 pm |
NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer |
2,160 | $26.81 | $57,906 | 31,437 (Direct) |
View |
| 2024-11-02 Sale |
2024-11-06 4:27 pm |
NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer |
44 | $16.69 | $734 | 79,217 (Direct) |
View |
| 2024-10-31 Sale |
2024-11-04 4:34 pm |
NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer |
810 | $15.79 | $12,792 | 110,093 (Direct) |
View |
| 2024-11-01 Sale |
2024-11-04 4:34 pm |
NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology |
598 | $15.94 | $9,531 | 161,236 (Direct) |
View |
| 2024-11-01 Sale |
2024-11-04 4:32 pm |
NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer |
160 | $15.88 | $2,540 | 3,503 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-04 Option Award |
2025-03-06 4:48 pm |
2026-03-04 2035-03-03 |
NovoCure Ltd | NVCR | Brackmann Christoph Chief Financial Officer |
136,474 | $18.19 | 202,649 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:42 pm |
2026-03-04 2035-03-03 |
NovoCure Ltd | NVCR | Leupin Nicolas Chief Medical Officer |
136,474 | $18.19 | 186,607 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:42 pm |
2026-03-04 2035-03-03 |
NovoCure Ltd | NVCR | Ben Arye Barak General Counsel |
136,474 | $18.19 | 255,195 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:41 pm |
2026-03-04 2035-03-03 |
NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer |
136,474 | $18.19 | 245,180 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:41 pm |
2026-03-04 2035-03-03 |
NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer |
136,474 | $18.19 | 302,717 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:41 pm |
2026-03-04 2035-03-03 |
NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology |
136,474 | $18.19 | 280,147 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:40 pm |
2026-03-04 2035-03-03 |
NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer |
136,474 | $18.19 | 165,647 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:39 pm |
2026-03-04 2035-03-03 |
NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer |
375,304 | $18.19 | 579,309 (Direct) |
View |
Ownership |
2025-01-06 4:10 pm |
N/A N/A |
NovoCure Ltd | NVCR | Brackmann Christoph CFO |
0 | $0 | 162,717 (Direct) |
View |
| 2024-12-31 Option Award |
2025-01-03 4:04 pm |
N/A N/A |
NovoCure Ltd | NVCR | Ben Arye Barak General Counsel |
669 | $14.75 | 118,721 (Direct) |
View |
| 2024-12-31 Option Award |
2025-01-03 4:04 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer |
373 | $14.75 | 219,552 (Direct) |
View |
| 2024-12-31 Option Award |
2025-01-03 4:04 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Director |
412 | $14.75 | 415,640 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 4:04 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Director |
400,000 | $0 | 415,640 (Direct) |
View |
| 2024-11-04 Option Award |
2024-11-06 4:27 pm |
N/A 2034-11-03 |
NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer |
45,620 | $16.59 | 79,217 (Direct) |
View |
| 2024-11-04 Option Award |
2024-11-06 4:27 pm |
N/A N/A |
NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer |
30,138 | $0 | 79,217 (Direct) |
View |
Ownership |
2024-10-09 6:21 pm |
N/A N/A |
NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer |
0 | $0 | 134,850 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-06 4:22 pm |
N/A N/A |
NovoCure Ltd | NVCR | Ben Arye Barak General Counsel |
930 | $12.24 | 118,052 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-06 4:21 pm |
N/A N/A |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
1,055 | $12.24 | 252,290 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-06 4:19 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
1,239 | $12.24 | 15,228 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-06 4:19 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
1,286 | $12.24 | 220,465 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-06 4:17 pm |
N/A N/A |
NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology |
1,736 | $12.24 | 161,834 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-06 4:16 pm |
N/A N/A |
NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer |
1,736 | $12.24 | 110,903 (Direct) |
View |